Drugs / Engerix B® Pediatric
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00362336 Comparator | Aug 2006 → May 2008 | diphtheria, haemophilus infectious disease, hepatitis B virus infection, pertussis +1 | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Engerix B Pediatric | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00362336 ↗ |
| Known as | Engerix B | “Group 3: DTaP-IPV-Hep B-PRP-T (ENGERIX B™ at birth)” NCT00362336 ↗ |
| Modality | Vaccine | “hepatitis B vaccine at birth” PMID 21289531 ↗ Apr 2011 |
| Route | Intramuscular | “0.5 mL, IM” NCT00362336 ↗ |